SPHK1 and cancer: Anti-intuitively, despite increased S1P levels in these experiments, reduction of SphK2 suppressed proliferation and migratory potential of cells more effectively than SphK1 ablation indicating targeting SphK2 may have stronger anti-cancer effects in cancer therapy [220].